Texas A&M Health Science Center’s faculty members regularly pursue innovative translational research to find solutions to some of today’s most pressing health conditions. However, some of these groundbreaking discoveries do not successfully move from the bench to the bedside because researchers find they have limited training when it comes to commercialization.
Founded on an initial discovery from researchers at the TAMHSC Institute of Biosciences and Technology, ECM Technologies – a Houston-based biotech startup – is looking to bring a new, bacterial-derived designer collagen to market.
Biomedical research should ultimately benefit patients. That’s the driving force behind the work being done by LauraLee Hughes and her staff in the Texas A&M Health Science Center’s Office of Technology Translation (OTT).
Texas A&M Technology Commercialization recently honored faculty across the Texas A&M University System whose inventions were granted patent protection in 2013 from the US Patent and Trademark Office